Add BrightSurf on Google Email

Science News for May 31, 2009


Penn researchers discover genetic risk factor for testicular cancer

A study published in Nature Genetics found that men with two copies of the KITLG gene have a 4.5-fold higher risk of testicular cancer, while those with two copies of the SPRY4 gene have a 1.48-fold higher risk. The discovery sheds light on genetic factors contributing to the disease and may help identify critical environmental factors.

Liver disease 'shrunk' by blood-pressure drug

A clinical trial has shown that losartan, a blood-pressure medicine, can shrink liver scarring and allow the organ to repair itself in some patients with early-stage liver failure. The drug works by blocking a signalling pathway that causes scar tissue to accumulate, allowing the damaged area of the liver to be repaired.

SourceNewcastle University·JournalGASTROENTEROLOGY·DateMay 31, 2009

International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury

Researchers have discovered genetic markers that predict individuals at risk for serious drug-induced liver injury. The study found that HLA-B*5701 is a major determinant of liver injury induced by flucloxacillin, and variations on chromosome 3 also influence the risk.